Losartan potassium (LP) is an angiotensin receptor blocker used to treat hypertension. At higher pH, it shows poor aqueous solubility, which leads to poor bioavailability and lowers its therapeutic effectiveness. The main aim of this research was to develop a direct compressed effervescent floating matrix tablet (EFMT) of LP using hydroxyl propyl methylcellulose 90SH 15,000 (HPMC-90SH 15,000), karaya gum (KG), and an effervescent agent, such as sodium bicarbonate (SB). Therefore, an EFMT has been developed to prolong the stomach residence time (GRT) of a drug to several hours and improve its bioavailability in the stomach region. The blended powder was evaluated for pre-compression characteristics, followed by post-compression characteristi...
Floating drug delivery system is one of the novel drug delivery system. Floating drug delivery syste...
In the present study, an effort was made to develop the pulsatile drug delivery of Losartan potassiu...
Sustained release matrix tablets of 100 mg losartan potassium HCl were fabricated with two release r...
The present study was aimed towards the development of controlled release formulations of Losartan P...
Objective: The current study was projected to prepare a losartan potassium gastroretentive drug deli...
Floating microspheres of Losartan potassium was prepared solvent evaporation method with an aim of i...
Objective: The objective of the present investigation was to the development of floating pulsatile d...
The objective of the present study is optimization of losartan floating tablet formulation by 23 fac...
The aim of the present study was to develop a controlled porosity osmotic tablet of Losartan potassi...
The objective of the present study was to develop hydrophilic polymer and hydrophobic polymer based ...
Osmotically controlled oral drug delivery systems utilize osmotic pressure as energy source for the ...
Purpose: To develop an optimised press-coated tablets of losartan potassium using an admixture of a ...
Osmotically controlled oral drug delivery systems utilize osmotic pressure as energy source for the ...
Angiotensin-II receptor blocker losartan, approved by the FDA in 1995, is used to treat hypertension...
Background: Antihypertensive drug telmisartan (TEL) belongs to BCS class II, which is characterized ...
Floating drug delivery system is one of the novel drug delivery system. Floating drug delivery syste...
In the present study, an effort was made to develop the pulsatile drug delivery of Losartan potassiu...
Sustained release matrix tablets of 100 mg losartan potassium HCl were fabricated with two release r...
The present study was aimed towards the development of controlled release formulations of Losartan P...
Objective: The current study was projected to prepare a losartan potassium gastroretentive drug deli...
Floating microspheres of Losartan potassium was prepared solvent evaporation method with an aim of i...
Objective: The objective of the present investigation was to the development of floating pulsatile d...
The objective of the present study is optimization of losartan floating tablet formulation by 23 fac...
The aim of the present study was to develop a controlled porosity osmotic tablet of Losartan potassi...
The objective of the present study was to develop hydrophilic polymer and hydrophobic polymer based ...
Osmotically controlled oral drug delivery systems utilize osmotic pressure as energy source for the ...
Purpose: To develop an optimised press-coated tablets of losartan potassium using an admixture of a ...
Osmotically controlled oral drug delivery systems utilize osmotic pressure as energy source for the ...
Angiotensin-II receptor blocker losartan, approved by the FDA in 1995, is used to treat hypertension...
Background: Antihypertensive drug telmisartan (TEL) belongs to BCS class II, which is characterized ...
Floating drug delivery system is one of the novel drug delivery system. Floating drug delivery syste...
In the present study, an effort was made to develop the pulsatile drug delivery of Losartan potassiu...
Sustained release matrix tablets of 100 mg losartan potassium HCl were fabricated with two release r...